Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology (Record no. 77115)

MARC details
000 -LEADER
fixed length control field 02395naaaa2200313uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/57911
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220220085355.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number intechopen.77687
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789840094
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789840100
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781839622106
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/intechopen.77687
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Denis Larrivee
Relationship auth
245 10 - TITLE STATEMENT
Title Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (134 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. It is fair to say that no brain disease occupies more research study today than Alzheimer's disease (AD). Among the many excellent reasons for this circumstance are the bleak prognosis and relentless progression; large cohorts of baby boomers entering an age of greatly increased cognitive risk; and spectacular advances in medical care that have prolonged lifespan. Often unattributed is the success of the research enterprise that has instilled confidence in AD's ultimate defeat. Yet, despite decades of intense research, AD remains poorly understood, an enigma amid a tide of neuroscientific advance. What these inconclusive results apparently call into question is an understanding of cognition that views it from the bottom up - the study of which is eminently suited by the scientific method - and that dispenses with a philosophy of biology concerned with how organismal properties operate, for which cognition is the medium. Culled from AD's new and old research archives, the chapters in this text accordingly lay out an argument for strategically new pathways that wander through cognition's global terrain and that may ultimately offer surer ground for AD treatment.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction All rights reserved
-- http://oapen.org/content/about-rights
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Medicine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Neuropsychiatry
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Mental and Behavioural Disorders and Diseases of the Nervous System
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Health Sciences
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://www.intechopen.com/books/redirecting-alzheimer-strategy-tracing-memory-loss-to-self-pathology">https://www.intechopen.com/books/redirecting-alzheimer-strategy-tracing-memory-loss-to-self-pathology</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/57911">https://directory.doabooks.org/handle/20.500.12854/57911</a>
Access status 0
Public note DOAB: description of the publication

No items available.